chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a noncontactable healthcare professional. A 25-year-old female patient (unknown if pregnant) received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8729), at the age of 25, via an unspecified route of administration, left arm, on Apr 22, 2021, at 12:30, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On Apr 22, 2021, patient experienced soreness in left arm and swelling for two days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The outcome of the soreness in left arm and swelling recovered on Apr 24, 2021 after duration of two days. No follow-up attempts needed. No further information expected.
I am 67 years old and post-menopausal. On April 26, I began experiencing what looked like menstrual bleeding. There was no warning: no pain. No cramps. Very few clots. Flow was moderate, but lasted on and off until it stopped completely on May 1. I want to report this, because I have seen recent reports (just beginning) to emerge from credible sources that other post-menopausal women are experiencing this type of bleeding after being vaccinated. I am concerned, frightened, and trying to make an appointment to see my gynecologist. The flow and length of days involved pretty much mimicked the menstrual pattern I had before menopause. But I should not be bleeding at this age. This has never happened since I ceased menstruating at age 52 or 53. I think the CDC should know my story, here.
This case was reported by a physician and described the occurrence of injection site pain in an 18 year old female pt who received hep B vaccine recombinant (Engerix B) for prophylaxis. On 8/13/03, the pt received inadvertently received the adult dosage of Engerix B (5386A2). Immediately post-immunization, she experienced "severe stinging and pain" at the injection site, which resolved after two minutes. The reporting physician suspected an "unusual or abnormal vaccine lot"; however, the physician also reported that patients who previously received this lot of vaccine did not experience pain.
Area at left arm SQ Varicella vaccine site red, 7cm, swollen, and hot to touch. Evaluated by private care physician - ice to local area & Ibuprofen prn recommended. Instructed to return to Md. if area gets larger or streaks, according to mother, on 11/10/10.
Patient states she was administered the flu shot at her workplace less than two hours ago, and that she started having symptoms about 30-40 minutes later, including "feeling hot," a rash to the right upper arm (near the injection site), feeling her neck was swollen and a globus sensation (but denies feeling her throat is closing), myalgias, fatigue, arthralgias, nausea, increased sweating, and injection site pain. She does endorse some measure of chronic constipation, and also that she has a history of "scalp dysesthesia" for which she uses a topical medication that she cannot recall the specific name. She endorses now that she is "feeling hot" similarly to how she feels her scalp feels with this condition, but that it is more widespread in her body. She is unsure if she has any egg allergy. She denies current headache, lightheadedness/dizziness, visual disturbance, eye pain, nasal congestion/sinus pressure, sore throat, trouble swallowing, trouble breathing, chest pain/palpitations, or n/v/d.  Administered dexamethasone 10 mg/mL injection solution (4 mg) by injection route for one dose, instructed to take several doses of diphenhydramine by mouth (12.5-25mg), and follow up with PCP later today.
SORE THROAT; JOINT PAIN; CHILLS; FEVER; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: UNKNOWN) dose was not reported, administered on 30-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-JUN-2021, the subject experienced sore throat. On 02-JUN-2021, the subject experienced joint pain. On 02-JUN-2021, the subject experienced chills. On 02-JUN-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore throat, fever, joint pain and chills was not reported. This report was non-serious.
Slight headache; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Slight headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus, Blood pressure high and Thyroid disorder. Concomitant products included LEVOTHYROXINE for Thyroid disorder, METFORMIN and BISOPROLOL FUMARATE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Slight headache). At the time of the report, HEADACHE (Slight headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient had no allergies. Patient did not had COVID positive test or diagnosis. No treatment information was provided.   This case was linked to MOD-2022-667382 (Patient Link).   Reporter did not allow further contact
Patient's right elbow swelled up and was painful starting 8/27/2023. His right arm continued to swell in both directions, but mainly radiating upwards, for the next couple of days. The swelling and pain started to go down about two days ago, but is still tender
Patient's age was 11 years and 9 months at the time of first injection. Second injection patient was 11 years and 10 months of age.  Guardian had denoted on paperwork that patient was 12 years old at the time of both injections.
She began lightheaded; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for Covid-19 immunization. The patient medical history was not reported.The patient's concomitant medications were not reported. On an unspecified date the patient experienced she began lightheaded. The outcome of event was unknown.  Information about batch/lot number has been requested.
Severe autoimmune reaction including: Headache, dizziness, chills, muscle aches, joint pain, fatigue, sore injection site, swollen face/eyes, legs/ankles and abdominal area, elevated blood pressure, burning sensation in hands and feet, sore throat, back pain, itchy skin, stiff neck and body aches. Pain level is a 7-8 out of 10. Seen by doctors 3 times since the vaccination and symptoms still persist along with pain level of 6 out of 10. Swelling has gone down in all areas but is not fully resolved. The doctors stated that it would be a matter of time before the vaccine was eliminated from my system. Steroid medication was prescribed but I did not take it as the side effects are contraindicated.
patient reports period was delayed by 9 days compared to normal cycle. she felt regular menstrual symptoms (breast tenderness, increased chocolate cravings, etc) at her expected time of menstruation but period did not arrive for an additional 9 days
Pain in L arm and shoulder, lasted to the end of the month. Diagnose with acute lymphoblastic leukemia. Some of T-cells had problem and hospitalization was required.
Pt had an appointment for Moderna booster vaccine on 11/24. Correct route and dose of vaccine was drawn up for administration, however, there was an equipment failure where the Vanish Point syringe being used malfunctioned and the needle retracted prematurely. This resulted in patient receiving a partial dose of the Moderna, as some of the medication leaked out on to her skin. RN discussed with pt what had happened immediately and pt was informed that clinic would follow up with immunization program in the state  to determine proper course of action. CDC's recommendations in this scenario is to repeat dose immediately if a lower than authorized dose was given. As a result, RN discussed these recommendations with patient, and pt opted to call back when she was ready to schedule a repeat dose.
PT received PENTACEL, PREVNAR and Rotavirus at 5 1/2 weeks of age. CDC contacted: valided the vaccines.
1st dose 01/2021, 2nd dose not yet administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number 3PD3E, expiry date 8th October 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix on January 2021, batch number AL734, expiry date 8th October 2022).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 10-MAY-2022 Reporter's Comments: The pharmacist reported that patient has had greater than 6 months between doses and second dose not yet administered.   The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
This spontaneous report as received from a pharmacist refers to a 77 year old male patient. On 11-MAY-2012 the patient was vaccinated with ZOSTAVAX (lot number was reported as 0241AC; expired date 26-APR-2013) (dose, route and indication were not reported). On 27-JUN-2013 the patient experienced shingles after vaccination with ZOSTAVAX. The patient was hospitalized at an unknown hospital. The patient was given valacyclovir hydrochloride after discharged from hospital on an unknown date. The outcome of shingles was reported as recovering/resolving. Additional information is not expected.
He got his vaccine, they had him to wait as a precaution, about 20-30 minutes before he went to work. He did feel a little strange but did not affect his work ability. He understood the soreness for a couple of days. Then about after a week he noticed that the top corner and side of the left arm to the top of his left shoulder is very tender, feels like it is swollen, it hurts. He woke up this morning miserable. It bothers him at work and hurts a lot at night. It does not feel strained or sprained but has a difficult time putting on shirts and coats, etc.. Corner of the shoulder feels as if she gave him the shot too high on the left arm and the pain is right above it. He waited it about and now it's a nuisance. He does have an appointment tomorrow at 10:00 AM to have his shoulder looked at. He noticed that he can barely lift his arm to put on his deodorant when he gets out of a shower and does not remember lifting anything heavy and does lift anything heavy at work. The pain level is a 4-7 when it gives him a lot of problems. Throughout his work night it is a 3-4, but it does wake him up at night. He has taken some muscle relaxants and it helps it for a couple of hours. Says that the nurse said she may have hit a nerve and the needle was a little longer than the first one, which he did not even feel that one.
Patient was scheduled in the COVID Vaccine Clinic on 6/11/21. Per report, patient requested to be given Pfizer vaccine, however was mistakenly given the Johnson and Johnson/JANSSEN vaccine. Scheduling notes show that patient is to receive the Pfizer vaccine. Of note, patient is pregnant--approximately 28 weeks and 2 days at time of vaccine. Current workflow for this institution's COVID vaccine distribution from pharmacy mimics flu vaccine distribution, in which pharmacy does not receive a patient-specific order for verification. With COVID vaccines, the pharmacy receives a request for preparation without a patient name or awareness of the encounter assigned to the patient. The primary system build to catch wrong drug error is barcode scanning prior to administration. Followed up with patient to provide support. Patient understanding and doing well. No current adverse impact. Request made to include two additional checkpoints prior to administration. First checkpoint will occur during the .phrase order process to pharmacy. Person ordering vaccine will confirm with patient the requested vaccine. Second checkpoint will be prior to administration. Nurse administering vaccine will confirm again the requested vaccine.
Mom indicated that same day of vaccine patient started feeling lightheaded with some dizziness and that the lightheadedness has been ongoing. Mom indicated that patient had seasonal allergies as well and had no relief from taking Benadryl. Advised mom that lightheadedness may be due to some nasal congestion from seasonal allergies and may consider taking fluticasone nasal spray to help relieve the sinus pressure, mucus production, and other accompanying symptoms. Mom agreed to have patient utilize the fluticasone and follow-up with doctor if symptoms did not resolve.
On 4/13/05 parents notified child not using right arm, or not using wrist level. Notified 3cm SQ nodule, tender, and red (1cm of redness surrounding).
Miscarriage at 6.5 weeks of pregnancy. Estimated due date was 12/25. First pregnancy.
1 hr after Rabies #1 patient experienced generalized hives.  No other systemic symptoms.  Treated in ED with steroids and antihistamines with prompt resolution of symptoms.  No other vaccines administered.  only taking his usual daily Adderall.  no NSAIDs or Tylenol.  Rash started on L arm where vaccine was administered.
While I was working, a lady came to the counseling window to ask a question. She told me she had gotten a Johnson and Johnson COVID shot ten minutes before and stated her arms felt numb, tingly, and heavy. She asked whether this normal.  I told her it?s not a normal, common side effect. I asked her if she had a history of reactions to vaccinations. She told me she hadn?t. I asked her for her name and phone number so I can report it to VAERs.  She then complained of sudden numbness in her upper lip. I realized it might be an allergic reaction. I grabbed a chair and had her sit down. I then got an epipen and went into the office to tell a manager to call 911.  I went back to check on the customer and asked how she was doing. She stated her throat was starting to tingle. I noticed upper lip was starting to swell. I asked her if she could wait for the paramedics to arrive, but she asked me to give her the epipen shot. She mentioned she got an epipen shot when she young. She didn?t know what she?s allegoric to, but this wasn?t the first time she was given an epipen shot.  I gave her the shot. She started feeling better, and I gave her some water and some candy because she appeared to be in a state of low-sugar. The paramedics arrived shortly after this. I explained the situation to the paramedics and what I had done for the customer.  Leaving the customer in the care of the paramedics, I went back to the pharmacy. She left with the paramedics shortly after this.
This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine; batch/lot# EN6208), at the age of 76, via an unspecified route of administration, in the left arm, on Mar 11, 2021, single dose, for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medication included losartan. The patient stated she was sick over the weekend, from Friday to Monday. The patient had the COVID-19 shot on Mar 11, 2021. She was supposed to have the second one on Apr 1, 2021. The patient stated she felt really bad. She did not know whether it was a side effect or what was going on; so she called the doctor. They asked whether the patient had a fever. She replied she had a fever for 14 days. The patient took a Tylenol for the fever and took a saline for her nose for being stuffy. The patient had a telephone office visit. She was informed to get a COVID-19 test before she the second vaccination. The doctor told her not to take her second shot until she was sure she did not have COVID-19 when she got sick. The patient further stated she was not sick at the time of report. Because she did not feel sick anymore on Monday, she went to the doctor. The patient stated she was just exhausted and tired. She did not have a fever. The outcome of fever and 'was sick' recovered. The outcome of 'exhausted and tired:' not recovered. The outcome of other events: unknown. No follow-up attempts possible. No further information expected.
Pt notes that after she received her pneumonia vaccine she developed marked swelling, redness and pain in her entire arm soon after, lasted about 3 days and then spontaneously resolved.
At 4 am I passed out and banged my head. Dizziness might have caused this. I got the vaccine the prior day at 11 am.
Intermittent headaches, joint pain, body aches, and fatigue despite vaccination being 3 weeks ago
What I thought was a sebaceous cyst in my jowl area between cheek and chin had been very slowly growing over about a three year period.  The day I got my second Moderna shot it became painful for the first time ever and roughly tripled in size.
Moderate back pain and shooting pain up and down legs; Rash on abdomen.; 24 hours after vaccine had moderate back pain; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8732) via an unspecified route of administration in the arm right on 06May2021 (at the age of 62-year-old) and second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8732) via an unspecified route of administration in the arm right on 28May2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disease. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, 24 hours after vaccine, the patient had moderate back pain and shooting pain up and down legs which lasted for 24 hours and 48 hours after vaccine, the patient had rash on abdomen. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events back pain, shooting pain up and down in legs and rash on abdomen were unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Comirnaty (12 yr ) vaccine was given to 6 yr old  by mistake
pt recv 1st vax w/small area of itching p/10 days;pt exp 3" diameter itching p/3 days;p/3rd vax 1/2 dollar size w/itching p/15min;treated w/IM DPH, icepack, APAP;erythema extended from shoulder to elbow next day
The vial used to give the vaccine expired yesterday (5/3/2022).  It was kept under appropriate conditions, and the patient has had no untoward effects thus far.
Stroke, right side basal ganglia, left side hemiparisis. Immediate transport to emergency room, 4 days hospitalization in Pediatric ICU.
Fever; Weakness in her head; Weakness in her head; Blood pressure was down/blood pressure went down to 80; Her heart rate went down; She couldn't even lift her head or lift her arms; Every time she got down, she was definitely ill; This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team.  An 83-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 immunization, reaction(s): "Weakness in her head", "Blood pressure was down/blood pressure went down to 80", "Weakness in her head", "Her heart rate went down", "Every time she got down, she was definitely ill", "She couldn't even lift her head or lift her arms", "Fever"; Bnt162b2 (DOSE 2), for COVID-19 immunization, reaction(s): "Weakness in her head", "Blood pressure was down/blood pressure went down to 80", "Weakness in her head", "Her heart rate went down", "Every time she got down, she was definitely ill", "She couldn't even lift her head or lift her arms", "Fever". The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Fever"; ASTHENIA (non-serious), HEAD DISCOMFORT (non-serious), outcome "unknown" and all described as "Weakness in her head"; BLOOD PRESSURE DECREASED (non-serious), outcome "recovered", described as "Blood pressure was down/blood pressure went down to 80"; HEART RATE DECREASED (non-serious), outcome "recovered", described as "Her heart rate went down"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "recovered", described as "She couldn't even lift her head or lift her arms"; ILLNESS (non-serious), outcome "recovered", described as "Every time she got down, she was definitely ill". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201293068 Same patient, drug, and events; different dose;US-PFIZER INC-202201293433 same patient/drug/event; different dose;
L arm cellulitis and lymphangitis X 2 days. treated with Keflex.
16 YEAR OLD WAS GIVEN MODERNA COVID VACCINE. NO ADVERSE REACTIONS OCCURRED.
Menstrual cycle started 10/28/2021 Covid booster given 10/30/2021 Patient menstrual cycle usually lasts around 5 days. as of 11/16/2021, patient was still having continuous vaginal bleeding and worsening anemia.
Approximately 3-4 minutes after receiving vaccine, patient became hot, nauseous. Then patient slumped over and passed out and fell out of chair onto the floor bumping her head. Patient had an approximately 20 second seizure. During this time 911 was called and EMS was activated. Patient came to, sat up, and was confused about whereabouts after seizure. She was informed of what happened and continued to have a conversation while waiting on EMS. Patient was provided a water and assisted into chair where RPH observed and monitored patient until EMS arrived.  EMS arrived and checked vitals, asked her medical history, her diet for the day, and performed a blood glucose test. EMS performed an evaluation for possible head injury. After about 10-15 minutes EMS and the patient made the decision to not transport to hospital. EMS informed patient and fiance to seek emergency care if status changed. Patient was able to leave the Pharmacy and store without assistance.